Using mucus for localized drug delivery in inflammatory bowel disease treatment

Katherine De Lange

doi:10.1063/10.0042323

January 21, 2026Scilight

Using mucus for localized drug delivery in inflammatory bowel disease treatment

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to improve drug delivery methods for inflammatory bowel disease using synthetic mucus gels.
Utilized synthetic mucus gels as drug carriers.
Focused on the delivery of monoclonal antibodies.
Assessed effects on immunosuppression levels.
Demonstrated effective localized delivery of monoclonal antibodies.
Reduced the risk of broad immunosuppression during treatment.

Implication

This approach shows effective localized drug delivery in inflammatory bowel disease, implying reduced side effects.

Abstract

In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Katherine De Lange (2026) studied this question.

synapsesocial.com/papers/69731089c8125b09b0d20457 https://doi.org/10.1063/10.0042323

View Full Paper

Ask AI

Bookmark

Share

Using mucus for localized drug delivery in inflammatory bowel disease treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Using mucus for localized drug delivery in inflammatory bowel disease treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading